Bristol Myers Squibb (BMY)

SG&A Expenses

$7.41B

TTM · Period ending: · USD

BMY logo

BMY SG&A Expenses

Latest reported$7.41B
BMY TTM SG&A Expenses ($0.00 → $7.41B)
High-resolution chart · PNG

BMY sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
7,413,000,000
7,300,000,000
7,267,000,000
7,222,000,000
7,416,000,000
7,631,000,000
8,414,000,000
8,351,000,000
8,371,000,000
8,377,000,000
7,772,000,000
7,965,000,000
7,892,000,000
7,745,000,000
7,814,000,000
7,902,000,000
7,760,000,000
7,855,000,000
7,690,000,000
8,057,000,000
7,975,000,000
7,721,000,000
7,661,000,000
6,674,000,000
6,023,000,000
5,471,000,000
4,871,000,000
4,473,000,000
4,522,000,000
4,577,000,000
4,551,000,000
4,585,000,000
4,644,000,000
4,700,000,000
4,805,000,000
4,921,000,000
4,921,000,000
4,997,000,000
5,002,000,000
5,066,000,000
5,127,000,000
5,035,000,000
5,001,000,000
5,555,000,000
5,559,000,000
5,571,000,000
5,699,000,000
4,944,000,000
4,927,000,000
5,105,000,000
5,104,000,000
5,268,000,000
5,298,000,000
5,165,000,000
5,178,000,000
5,166,000,000
5,149,000,000
5,214,000,000
5,160,000,000
4,927,000,000
4,826,000,000
4,690,000,000
4,660,000,000
4,131,000,000
4,217,000,000
4,308,000,000
4,449,000,000
5,477,000,000
5,838,000,000
6,175,000,000
6,375,000,000
6,359,000,000
6,232,000,000
6,104,000,000
6,052,000,000
6,030,000,000
6,062,000,000
6,138,000,000
6,270,000,000
6,354,000,000
6,514,000,000
6,614,000,000
6,582,000,000
6,554,000,000
6,443,000,000
6,357,000,000
6,398,000,000
6,324,000,000
6,283,000,000
6,237,000,000
6,110,000,000
5,891,000,000
5,681,000,000
5,462,000,000
5,218,000,000
5,167,000,000
5,080,000,000
5,188,000,000
5,305,000,000
5,190,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.